Lung cancer mortality trends in Mexico, 1999-2014

Hernández‐Garduño, Eduardo; Ocaña-Servín, H.L.

doi:10.21149/8730

Cited by 12 publications

(12 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…15 In the present study, we observed that the adjusted LC mortality rate decreased in Mexico and particularly in men, which is consistent with previous reports. 18 However, the decrease in the mortality rate was not uniform throughout the country. Therefore, resident populations of municipalities with high and very high marginalization showed a tendency with less decrease or even no decrease in both men and women.…”

Section: Discussionmentioning

confidence: 99%

“…[6][7][8] Furthermore, studies in different populations (e.g., Asiatic and Anglo-Saxon) document how the diagnosis and treatment may be different by socioeconomic and educational level. [15][16][17][18] For instance, a study showed that LC patients with lower SES compared to those with higher SES had a lower probability of undergoing surgery or chemotherapy. 15 Likewise, as the level of poverty of the community increased, the median survival decreased, concluding that extreme community poverty (> 15%) behaves as a factor of poor prognosis even after adjusting the for comorbidities, clinical characteristics or even the treatment received.…”

Section: Discussionmentioning

confidence: 99%

“…This exposure has decreased over time, both globally and in our country. 2,18,19 However, the assessment of this factor on LC incidence in our country remains limited derived from the lack of a national cancer registry.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Lung cancer mortality and municipal marginalization in Mexico, 1998-2016

Ramírez-Tirado¹,

Uribe-Ortiz

Arrieta³

et al. 2019

Salud Publica Mex

View full text Add to dashboard Cite

Objective. To analyze the mortality trend of lung cancer (LC) in Mexico, according to the municipality marginalization index (MMI) by age group and sex, during the period 1998-2016. Materials and methods. The information on mortality, population and MMI was obtained from the National Institute of Statistics and Geography (INEGI) and the National Council of Population (Conapo). The adjusted LC mortality rate trends were analyzed using the joinpoint regression analysis. A total of 126 132 deaths were included. Results. The adjusted LC mortality rate decreased from 7.83 to 4.97 100 000 inhabitants during the period from 1998-2016, but the decrease was found to be less in women and in areas with very high marginalization. Conclusions. Unequal reduction in LC mortality according to the degree of marginalization are related to early diagnosis, timely treatment and inequity in medical services. This inequity affects mainly the populations of women, highly marginalized groups and older populations.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Lung cancer mortality and municipal marginalization in Mexico, 1998-2016

Ramírez-Tirado¹,

Uribe-Ortiz

Arrieta³

et al. 2019

Salud Publica Mex

View full text Add to dashboard Cite

show abstract

“…5 In spite of the relative importance of LC in terms of incidence, previous literature has shown that the mortality rate from LC has decreased in the lasts two decades, particularly among men. [6][7][8][9] Although a reduction in mortality has been documented previously, it is important to note other health metrics related to the burden imposed by LC and to highlight geographic patterns. In particular, the Global Burden of Disease Study (GBD-2016) offers estimates of the burden of LC based on its impact on premature mortality and time lived with disability summarized in the number of Disability-Adjusted Life Years (DALYs).…”

Section: Introductionmentioning

confidence: 89%

Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016

et al. 2019

View full text Add to dashboard Cite

Objective. To show lung cancer (LC) mortality and disability-adjusted life years (DALYs) in Mexico. Materials and methods. With the visualization tools at the Global Burden of Disease Study website, we analyzed LC mortality and disability-adjusted life years (DALYs) by state, sex, sociodemographic index (SDI), age, and risk factors between 1990 and 2016. Results. Mortality rate decreased from 13.9 to 9.1 per 100 000 between 1990 and 2016. This reduction is greater among men. However, deaths by LC rose from 5 478 to 8 470. DALYs rate also decreased. Northern states with higher SDI face a larger burden from LC but exhibited greater reductions compared with southern, less developed states. The burden of LC is concentrated among older population. Smoking is the main risk factor for LC. Conclusions. The burden by LC has decreased but is differential between states. LC threatens financially both the health system and individuals, since an important fraction of the population is not protected.

show abstract

“…1 En México, esta neoplasia ocupa el primer lugar como causa de muerte por tumores malignos, 2,3 cuyo comportamiento mostraba tendencia ascendente hasta el año 1989, a partir del cual es ligeramente descendente tanto en hombres como en mujeres. [4][5][6] Es indiscutible que el humo del tabaco es la principal causa de estos tumores malignos de las vías respiratorias bajas. Al humo de tabaco se suma la exposición al humo de leña, otros contaminantes ambientales (asbesto, radón, fertilizantes), condiciones genéticas y estilos de vida poco saludables, 7 y condiciones laborales y socioeconómicas que son también importantes en la aparición de tumores de pulmón.…”

unclassified

Incidencia, mortalidad y costos de la atención por cáncer de pulmón en el Instituto Mexicano del Seguro Social

2019

View full text Add to dashboard Cite

Objetivo. Analizar la tendencia temporal de la incidencia y la mortalidad del cáncer de pulmón, así como los costos asociados con su atención médica. Material y métodos. Se estimó el número de casos incidentes a partir de los egresos hospitalarios de 276 hospitales del Instituto Mexicano del Seguro Social (IMSS) entre 2006 y 2016. Se calcularon tasas de mortalidad crudas y ajustadas. Los costos del tratamiento ambulatorio y hospitalario se calcularon con base en los costos médico-técnicos de referencia o costos estándar de 2015. Resultados. Tanto la incidencia como la mortalidad muestran tendencia descendente. El costo de la atención médica de los 2 539 pacientes de 2017 fue de 42 millones de dólares americanos, con costo promedio por paciente de 16 527 dólares americanos. El gasto promedio anual de pensiones por invalidez es de 97.2 millones de pesos. Conclusiones. Es probable que la reducción del riesgo de enfermar y morir por cáncer de pulmón en derechohabientes del IMSS se deba a las medidas de control del humo de tabaco. Todavía es necesario establecer estrategias para diagnosticar y tratar a los pacientes en estadios tempranos.

show abstract

Lung cancer mortality trends in Mexico, 1999-2014

Abstract: [No disponible]

Cited by 12 publications

References 7 publications

Lung cancer mortality and municipal marginalization in Mexico, 1998-2016

Lung cancer mortality and municipal marginalization in Mexico, 1998-2016

Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016

Incidencia, mortalidad y costos de la atención por cáncer de pulmón en el Instituto Mexicano del Seguro Social

Contact Info

Product

Resources

About